» Articles » PMID: 18495743

Glomerular Expression of Monocyte Chemoattractant Protein-1 is Predictive of Poor Renal Prognosis in Pediatric Lupus Nephritis

Overview
Date 2008 May 23
PMID 18495743
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Monocyte chemoattractant protein-1 (MCP-1) is upregulated and it recruits and activates inflammatory cells in murine lupus nephritis (LN).

Methods: Clinical outcomes of children with LN were examined in relation to glomerular expression of MCP-1 and macrophage infiltration, as determined by immunohistochemical staining of renal biopsy sections with MCP-1 and CD68. Sections were analysed using a modified histological score (H-score; maximum of 300) based on both percentage of positively stained cells and intensity of staining.

Results: Renal biopsies were examined from 34 children [27 (79%) female] aged 7.7-17.3 (median 13.7) years with 50% ISN/RPS Class IV LN. Renal dysfunction and proteinuria at follow-up of 2.2-15.4 (median 6.5) years were analysed with estimated glomerular filtration rates (eGFR) of 11.2-124.1 (median 93.6) ml/min/1.73 m(2) and urine albumin:creatinine ratios of 1-535 (median 63) mg/mmol. There was a correlation between glomerular expression of MCP-1 and CD68 (r = 0.98, P = 0.04; median modified H-score of 219.7 and 230.8, respectively). Patients with Class III and IV LN had increased glomerular expression of both MCP-1 and PGM1 compared to the other classes (P = 0.01) with Class IV-G LN patients having the most glomerular expression of MCP-1 (median of 227.3) and PGM1 (median of 237.5) and the worst renal prognosis (with proteinuria and reduced eGFR).

Conclusions: There is a correlation between glomerular expression of MCP-1 and PGM1 and worsening renal prognosis in paediatric LN. Larger prospective studies of paediatric LN are required to further evaluate MCP-1 and other markers of disease progression.

Citing Articles

Single-cell mass cytometry in immunological skin diseases.

Zhao M, Cheng Y, Gao J, Zhou F Front Immunol. 2024; 15:1401102.

PMID: 39081313 PMC: 11286489. DOI: 10.3389/fimmu.2024.1401102.


Macrophages of the Cardiorenal Axis and Myocardial Infarction.

Kercheva M, Ryabov V, Gombozhapova A, Stepanov I, Kzhyshkowska J Biomedicines. 2023; 11(7).

PMID: 37509483 PMC: 10376845. DOI: 10.3390/biomedicines11071843.


The therapeutic applications of mesenchymal stromal cells from human perinatal tissues in autoimmune diseases.

Yang C, Wu M, You M, Chen Y, Luo M, Chen Q Stem Cell Res Ther. 2021; 12(1):103.

PMID: 33541422 PMC: 7859900. DOI: 10.1186/s13287-021-02158-3.


A panel of urinary proteins predicts active lupus nephritis and response to rituximab treatment.

Davies J, Carlsson E, Midgley A, Smith E, Bruce I, Beresford M Rheumatology (Oxford). 2020; 60(8):3747-3759.

PMID: 33313921 PMC: 8328509. DOI: 10.1093/rheumatology/keaa851.


The human glomerular endothelial cells are potent pro-inflammatory contributors in an in vitro model of lupus nephritis.

Dimou P, Wright R, Budge K, Midgley A, Satchell S, Peak M Sci Rep. 2019; 9(1):8348.

PMID: 31171837 PMC: 6554346. DOI: 10.1038/s41598-019-44868-y.